HCV DAA | ART drug name | Effect on concentration | Comments |
---|---|---|---|
Sofosbuvir/Velpatasvir | |||
 | Efavirenz | â velpatasvir | Coadministration not recommended |
Tenofovir disoproxil (TDF) | â tenofovir | Renal monitoring for tenofovir associated adverse reactions. | |
Tipranavir/ritonavir | â sofosbuvir â velpatasvir | Coadministration not recommended | |
Glecaprevir/Pibrentasvir | |||
 | Atazanavir | â glecaprevir â pibrentasvir | Coadministration contraindicated due to increased risk of ALT elevations |
Darunavir/Lopinivir/ritonovir | â glecaprevir â pibrentasvir | Coadministration not recommended | |
Efavirenz | â glecaprevir â pibrentasvir | Coadministration not recommended |